Klaas van Gisbergen

20 April 2023

2023 European Researchers' Night

The second edition of the European Researchers’ Night (ERN), organised by the RAISE - Researchers in Action for Inclusion in Science and Education consortium will be held on the 29th of September 2023 and will, once again, take place at the Champalimaud Foundation (Lisbon).

The main goal of this public event, organised by consortium partners, Native Scientists, Champalimaud Foundation and Instituto de Medicina Molecular, is to promote, actively and effectively, diversity and inclusion in science and education.

Mário Inácio

13 April 2023

One brain, multiple and simultaneous alternative decision strategies

A study published today, April 13th, in the journal Nature Neuroscience provides a surprising answer to this question by showing that, rather than committing to a single strategy, the brain can compute multiple alternative decision strategies simultaneously.

The study, led by Fanny Cazettes and senior authors Zachary Mainen and Alfonso Renart, at the Champalimaud Foundation in Lisbon, Portugal, performed a specially-designed experiment which used a kind of “virtual reality” setup for mice, in which the animals were tasked with searching for water in a virtual world. 

Jaime Caballero

Matilde Sedas

03 April 2023

Let’s talk about Multiple Myeloma

March was Multiple Myeloma Awareness Month. In this short video, Cristina João, Haemato-oncologist of the Haemato-oncology Unit at the Champalimaud Foundation, explains what this pathology is and talks about the activities that the Unit has developed for improving the care of people with Multiple Myeloma. She also points out that, in addition to clinical activity, the Haemato-Oncology Unit does translational research through the Foundation's Lymphoma and Myeloma Research Group, which she leads.

Carlos Minutti

31 March 2023

Research within the Watch&Wait Programme

Neste último vídeo da série, Laura Fernández, Cirurgiã Colorretal, fala da investigação da equipa sobre o Protocolo Watch&Wait (W&W).

Em estudos recentes, mostraram que a probabilidade de os doentes com cancro retal, que permanecem livres de tumores durante cinco anos, voltarem a desenvolver a doença é quase nula. Atualmente, a equipa está a tentar determinar quais os doentes, integrados no programa W&W, que serão mais susceptíveis de apresentar metástases.

AI and Machine Learning in Cancer Imaging 3.0

On behalf of the International Cancer Imaging Society (ICIS) and the Champalimaud Foundation, we would like to invite you to register for our jointly hosted meeting 'AI and Machine Learning in Cancer Imaging 3.0', which will be held on 30 June and 1 July 2023.  The meeting will take place at the Champalimaud Centre for the Unknown, in Lisbon. 

Subscribe to Researchers
Loading
Please wait...